Albert Galaburda

Last updated
Amelia Baker Lauderdale presents Albert Galaburda with the Einstein Award at Harvard Medical School. Dyslexia f'n ann conf einstein award 17-oct-13-18.jpg
Amelia Baker Lauderdale presents Albert Galaburda with the Einstein Award at Harvard Medical School.

Albert Mark Galaburda (born 20 July 1948 Santiago, Chile) is a cognitive and behavioral neurologist with a special focus on the biologic bases of developmental cognitive disorders. He is the Emily Fisher Landau Professor of Neurology and Neuroscience at Harvard Medical School, the Director of the Office for Diversity, Inclusion, and Career Advancement at Beth Israel Deaconess Medical Center, Boston, and co-director of the Harvard University Interfaculty Initiative on Mind Brain and Behavior, together with psychologist Alfonso Caramazza. [1] He is best known for his development of the Geschwind–Galaburda hypothesis, which helps explain differences in cognitive abilities on the basis of sex hormones and immunological characteristics and their relationship to lateralization of brain function, as well as for his pioneering studies on the biological foundations of developmental dyslexia. [2] Other work includes the anatomical organization of the auditory cortex in the brains of monkeys and humans and the neuroanatomical and neurodevelopmental bases of brain laterality and asymmetry. He attended the Six-Year Liberal Arts-Medicine Program at Boston University School of Medicine, graduating with an AB-MD degree in 1971, and completed a residency in Internal Medicine and a residency in Neurology at Boston City Hospital, now Boston Medical Center. [3] He was trained in Medicine under Norman Levinsky and in Neurology under Norman Geschwind. [4] He has published numerous scientific articles and books in the field of cognitive neurology, with a focus on learning disabilities and attention disorders, especially in adults.

In October 2017, he received The Dyslexia Foundation's Einstein Award, which honors an individual who is not dyslexic, but has made significant contributions to increasing our understanding of dyslexia and improving the lives of individuals with dyslexia. [5] Other awards include the Pattison Prize in Neuroscience, Scientist of the Year from the Association for Children with Learning Disabilities, the Neuronal Plasticity Prize from the IPSEN Foundation of France, the Harold Amos Faculty Diversity Award from Harvard Medical School, and the Lifetime Achievement Award in Behavioral Neurology from the American Academy of Neurology. [6]

Related Research Articles

<span class="mw-page-title-main">Dyslexia</span> Specific learning disability characterized by troubles with reading

Dyslexia, previously known as word blindness, is a learning disability that affects either reading or writing. Different people are affected to different degrees. Problems may include difficulties in spelling words, reading quickly, writing words, "sounding out" words in the head, pronouncing words when reading aloud and understanding what one reads. Often these difficulties are first noticed at school. The difficulties are involuntary, and people with this disorder have a normal desire to learn. People with dyslexia have higher rates of attention deficit hyperactivity disorder (ADHD), developmental language disorders, and difficulties with numbers.

The following outline is provided as an overview of and topical guide to neuroscience:

A reading disability is a condition in which a person displays difficulty reading. Examples of reading disabilities include developmental dyslexia and alexia.

The Geschwind–Galaburda hypothesis is a neurological theory proposed by Norman Geschwind and Albert Galaburda in 1987. The hypothesis posits there are sex differences in cognitive abilities by relating them to lateralisation of brain function. The maturation rates of cerebral hemispheres differ and are mediated by circuiting testosterone levels, which are substantially influenced during the foetal and post-puberty development stages.

Samuel Torrey Orton was an American physician who pioneered the study of learning disabilities. He examined the causes and treatment of dyslexia.

<span class="mw-page-title-main">Behavioral neurology</span> Branch of medicine

Behavioral neurology is a subspecialty of neurology that studies the impact of neurological damage and disease upon behavior, memory, and cognition, and the treatment thereof. Two fields associated with behavioral neurology are neuropsychiatry and neuropsychology. In the United States, 'Behavioral Neurology & Neuropsychiatry' has been recognized as a single subspecialty by the United Council for Neurologic Subspecialties (UCNS) since 2004.

<span class="mw-page-title-main">Norman Geschwind</span> American behavioral neurologist (1926–1984)

Norman Geschwind was a pioneering American behavioral neurologist, best known for his exploration of behavioral neurology through disconnection models based on lesion analysis.

<span class="mw-page-title-main">Kenneth Heilman</span> American neurologist (1938–2024)

Kenneth M. Heilman was an American behavioral neurologist. He is considered one of the fathers of modern-day behavioral neurology.

The history of dyslexia research spans from the late 1800s to the present.

Dyslexia is a reading disorder wherein an individual experiences trouble with reading. Individuals with dyslexia have normal levels of intelligence but can exhibit difficulties with spelling, reading fluency, pronunciation, "sounding out" words, writing out words, and reading comprehension. The neurological nature and underlying causes of dyslexia are an active area of research. However, some experts believe that the distinction of dyslexia as a separate reading disorder and therefore recognized disability is a topic of some controversy.

Functional disconnection is the disintegrated function in the brain in the absence of anatomical damage, in distinction to physical disconnection of the cerebral hemispheres by surgical resection, trauma or lesion. Applications have included alexia without agraphia dyslexia, persistent vegetative state and minimally conscious state as well as autistic spectrum disorders. Functional disconnection itself is not a medically recognized condition. It is a theoretical concept used to facilitate research into the causes and symptoms within recognized conditions.

Clinical neuroscience is a branch of neuroscience that focuses on the scientific study of fundamental mechanisms that underlie diseases and disorders of the brain and central nervous system. It seeks to develop new ways of conceptualizing and diagnosing such disorders and ultimately of developing novel treatments.

Usha Claire Goswami is a researcher and professor of Cognitive Developmental Neuroscience at the University of Cambridge, a Fellow of St. John's College, Cambridge, and the director of the Centre for Neuroscience in Education, Downing Site. She obtained her Ph.D. in developmental psychology from the University of Oxford before becoming a professor of cognitive developmental psychology at the University College London. Goswami's work is primarily in educational neuroscience with major focuses on reading development and developmental dyslexia.

Daniel H. Geschwind is an American physician-scientist whose laboratory has made pioneering discoveries in the biology of brain disorders and the genetic and genomic analyses of the nervous system.

Jeffrey D. Macklis is an American neuroscientist. He is the Max and Anne Wien Professor of Life Sciences in the Department of Stem Cell and Regenerative Biology and Center for Brain Science at Harvard University, Professor of Neurology [Neuroscience] at Harvard Medical School, and on the Executive Committee and a Member of the Principal Faculty of the Neuroscience / Nervous System Diseases Program at the Harvard Stem Cell Institute.

<span class="mw-page-title-main">Roy Hamilton (physician)</span> American neurologist and academic

Roy Hamilton is professor in the departments of Neurology, Psychiatry, and Physical Medicine and Rehabilitation at University of Pennsylvania (Penn). He is the Director of Penn's Laboratory for Cognition and Neural Stimulation (LCNS), and launched the Brain Stimulation, Translation, Innovation, and Modulation Center (brainSTIM) at the University of Pennsylvania in 2020.

<span class="mw-page-title-main">Dominick P. Purpura</span> American neuroscientist (1927–2019)

Dominick P. Purpura was a neuroscientist. who was well known for his research focused on intellectual disability. His work also focused on the origin of brain waves, developmental neurobiology, and epilepsy. From 1982 to 1983, Purpura was appointed as the president of the Society for Neuroscience. In 1984, he was recruited to be the dean of Albert Einstein College of Medicine of Yeshiva University. He served as the dean for a total of 22 years.

<span class="mw-page-title-main">Andrew Budson</span> American neurologist

Andrew E. Budson is an American neurologist, academic and researcher. He is a Professor of Neurology at Boston University School of Medicine, Lecturer in Neurology at Harvard Medical School, Chief of Cognitive and Behavioral Neurology and Associate Chief of Staff for Education at the Veterans Affairs (VA) Boston Healthcare System, where he also serves as a Director of the Center for Translational Cognitive Neuroscience. He is Associate Director and Outreach, Recruitment, and Engagement Core Leader at the Boston University Alzheimer's Disease Research Center.

Reid Lyon is a neuroscientist (neuropsychology), specialist in learning disorders, and researcher on the science of reading.

<span class="mw-page-title-main">Francisco Aboitiz</span>

Francisco Aboitiz is a Chilean neuroscientist, academic, and author. He is a professor at the Medical School and the Director of the Interdisciplinary Center for Neuroscience NeuroUC at Pontificia Universidad Católica (PUC) de Chile.

References

  1. "Albert Galaburda". mbb.harvard.edu. Retrieved December 21, 2019.
  2. Geschwind, N.; Galaburda, A. M. (May 1985). "Cerebral lateralization. Biological mechanisms, associations, and pathology: I. A hypothesis and a program for research". Archives of Neurology. 42 (5): 428–459. doi:10.1001/archneur.1985.04060050026008. ISSN   0003-9942. PMID   3994562.
  3. "About Dr. Albert Galaburda, MD". August 20, 2019. Retrieved December 21, 2019.
  4. "Albert M. Galaburda, MD – Cognitive Neurology Unit (CNU) – BIDMC" . Retrieved December 21, 2019.
  5. "Dyslexia and Literacy: Differences within Differences – Harvard Medical School – October 2017 | The Dyslexia Foundation" . Retrieved December 21, 2019.
  6. "Brookes Publishing: Albert M. Galaburda, M.D." products.brookespublishing.com. Retrieved December 21, 2019.